NATH BIOGENES (INDIA)
Back to Cashflow Statement
|
NATH BIOGENES (INDIA) Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2013 | Mar2012 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹39 Cr | ₹34 Cr | ₹-25 Cr | ₹-0.81 Cr | - |
What is the latest Net Cash Inflow / Outflow ratio of NATH BIOGENES (INDIA) ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹39 Cr |
Mar2023 | ₹34 Cr |
Mar2022 | ₹-25 Cr |
Mar2013 | ₹-0.81 Cr |
Mar2012 | - |
How is Net Cash Inflow / Outflow of NATH BIOGENES (INDIA) Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹39 Cr | 16.56 | |
Mar2023 | ₹34 Cr | Positive | |
Mar2022 | ₹-25 Cr | Negative | |
Mar2013 | ₹-0.81 Cr | 0 | |
Mar2012 | - | - |
Compare Net Cash Inflow / Outflow of peers of NATH BIOGENES (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATH BIOGENES (INDIA) | ₹375.6 Cr | -1.5% | 3.1% | 0.7% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹13,151.0 Cr | -4.3% | -4.8% | 17.2% | Stock Analytics | |
KAVERI SEED COMPANY | ₹6,473.6 Cr | -4.4% | -9.7% | 36.7% | Stock Analytics | |
VENKYS (INDIA) | ₹2,261.5 Cr | -1.7% | -0.5% | -13.9% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,377.6 Cr | -4.3% | -6.5% | -30.7% | Stock Analytics | |
INDO US BIOTECH | ₹305.8 Cr | -3.6% | 3.7% | -19.6% | Stock Analytics |
NATH BIOGENES (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATH BIOGENES (INDIA) | -1.5% |
3.1% |
0.7% |
SENSEX | -0.4% |
0.2% |
5.9% |
You may also like the below Video Courses